L310-0577 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

L310-0577 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
L310-0577 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L310-0577
6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L310-0577

Molecular Formula

C21H21ClN4O6S (C21 H21 ClN4 O6 S)

Compound Name

6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

IUPAC name

6-chloro-4-[(5-ethyl-124-oxadiazol-3-yl)methyl]-N-(2-methoxy-5-methylphenyl)-3-oxo-34-dihydro-2H-14-benzoxazine-7-sulfonamide

SMILES

CCc1nc(CN(C(COc2c3)=O)c2cc(Cl)c3S(Nc(cc(C)cc2)c2OC)(=O)=O)no1

InChI

InChI=1S/C21H21ClN4O6S/c1-4-20-23-19(24-32-20)10-26-15-8-13(22)18(9-17(15)31-11-21(26)27)33(28,29)25-14-7-12(2)5-6-16(14)30-3/h5-9,25H,4,10-11H2,1-3H3

InChI Key

MWBAZDDYPMPXDQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244346

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.94

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.998

Distribution Coefficient, logD

2.985

Water Solubility, LogSw

-3.41

Polar Surface Area

104.256

Acid Dissociation Constant (pKa)

8.92

Base Dissociation Constant (pKb)

-4.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

L310-0577 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with L310-0577 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L310-0577?
Check Price and Availability of L310-0577, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L310-0577 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L310-0577
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L310-0577
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L310-0577 available by request